Independent pharmacies can maximize their marketing reach by focusing on care, relationships, and community involvement. Building a strong online presence with a professional website and active social media accounts helps provide information about services and...
This article discusses the ongoing privatization of Medicare and how private insurers are making significant profits through systematic overbilling and opposition to measures aimed at stopping the practice. It focuses on Humana, a prominent health insurance...
The Drug Supply Chain Security Act (DSCSA) was enacted by the U.S. Congress on November 27, 2013, and aims to build a comprehensive, interoperable system by 2023 to identify and trace prescription drugs as they are distributed in the United States. The four core...
The DSCSA aims to enhance product legitimacy verification, improve recall efficiency, and...
The FDA recently approved a new medication called Veozah (fezolinetant) for the treatment of moderate to severe hot flashes in menopausal women. Hot flashes are characterized by sudden waves of intense heat, followed by sweating and sometimes chills. Veozah is an...
In April, CVS Health, CEO Karen Lynch celebrated the acquisition of Oak Street Health, a primary care company specializing in treating Medicare-eligible patients. CVS has been expanding its presence in the healthcare industry by acquiring various companies,...
EnlivenHealth is hosting this webinar on Thur. May 25, 10:00 AM — 11:00 AM PDT
Join webinar host Jameson Groot, PharmD, and special guest Josh Miller, PharmD from HAC Pharmacies as they discuss the variety of obstacles that can get in the way of pharmacy efficiency —...
A recent analysis published in the Journal of the American Pharmacists Association highlights the expanding role of community pharmacies in filling patient care access gaps.
With nearly 90% of Americans living within five miles of a community pharmacy, these...
Walgreens remains committed to conducting clinical trials despite CVS Health's decision to wind down its clinical trial services by the end of 2024. Both companies launched their clinical trial businesses in the last two years when the US FDA was seeking to enroll...